Clinical Trials Logo

Filter by:
NCT ID: NCT05542537 Not yet recruiting - Obesity Clinical Trials

Nurturing Healthy Teachers

NHT
Start date: September 2022
Phase: N/A
Study type: Interventional

The purpose of this trial is to compare the impact of a fruit and vegetable access plus nutrition education intervention to a nutrition education-only control on the health, well-being, and food security of early care and education (ECE) professionals. The intervention, called Nurturing Healthy Teachers, combines strategies from two evidence-based programs - Create Healthy Futures (CHF) and Brighter Bites (BB).

NCT ID: NCT05539365 Not yet recruiting - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

Start date: October 1, 2024
Phase: Phase 2
Study type: Interventional

This phase II trial tests the safety, side effects, and whether dendritic cell-based treatment and pembrolizumab work in treating patients with triple negative breast cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). The term triple-negative breast cancer refers to the fact that the cancer cells don't have estrogen or progesterone receptors (ER or PR) and also don't make any or too much of the protein called HER2 (the cells test "negative" on all 3 tests). Dendritic cell-based treatment works by boosting the immune system (a system in our bodies that protects us against infection) to recognize and destroy the cancer cells. Pembrolizumab, is an immune checkpoint inhibitor drug, that works by targeting molecules that act as a check and balance system for immune responses. Immune checkpoint inhibitor drugs are designed to either "unleash" or "enhance" the cancer immune responses that already exist by either blocking inhibitory molecules or by activating stimulatory molecules. Giving dendritic cell-based therapy and pembrolizumab may decrease symptoms and improve quality of life in patients with triple negative breast cancer.

NCT ID: NCT05539352 Not yet recruiting - Suicidal Ideation Clinical Trials

Improving Caregivers' Ability to Manage Life Stress

Start date: June 3, 2024
Phase: N/A
Study type: Interventional

The COVID-19 pandemic has led to increased caregiving demands for caregivers of Veterans with dementia. Dementia caregivers are particularly at-risk for depression and anxiety, known risk factors for increased suicidality. Emerging research also suggests that dementia caregivers are experiencing greater suicidality during COVID-19 at a time when VHA is also devoting increased efforts toward caregiver health and support services. Aims are to determine the feasibility and acceptability of video-delivered Problem-Solving Therapy for reducing suicide risk in caregivers of Veterans with dementia.

NCT ID: NCT05537662 Not yet recruiting - Chronic Pain Clinical Trials

External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

XANADO
Start date: March 2023
Phase: N/A
Study type: Interventional

This is a prospective, longitudinal, single-center, non-randomized, open-label, post-market clinical feasibility study to assess the efficacy of neuromodulation therapies (SCS and DRG) for chronic pain patients with diabetes and investigate whether physical and physiological data collected from diabetic and pre-diabetic chronic pain patients is predictive of subjective patient-reported outcomes (PROs) and of adjustments in patient care. These assessments will be made prior to, during, and after the trial of the SCS or DRG system. The study will be carried out in the United States at a single site.

NCT ID: NCT05536895 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

C-arm Cone Beam CTP Guided Cerebrovascular Interventions

Start date: August 2024
Phase: N/A
Study type: Interventional

The study objective for the Phase 2 of this research is to demonstrate and confirm the substantial time savings that can be obtained using cone beam computed tomography (CB-CT) for both complete image acquisition and rapid image reconstruction in a Direct to Angio paradigm (One Stop Shop) for selected acute ischemic stroke (AIS) patients.

NCT ID: NCT05536739 Not yet recruiting - Stroke Clinical Trials

Adaptive Hip Exoskeleton for Stroke Gait Enhancement

Start date: January 1, 2026
Phase: N/A
Study type: Interventional

This work will focus on new algorithms for robotic exoskeletons and testing these in human subject tests. Individuals who have previously had a stroke will walk while wearing a robotic exoskeleton on a specialized treadmill. The study will compare the performance of the advanced algorithm with not using the device to determine the clinical benefit.

NCT ID: NCT05533671 Not yet recruiting - Patella Dislocation Clinical Trials

Conservative Versus Operative - First Time Patella Dislocations

Start date: December 2023
Phase: N/A
Study type: Interventional

There is no consensus regarding whether rehabilitation or surgical management is best for the management of a primary patellar dislocation. Consequently this prospective randomized controlled aims to compare the incidence of recurrent knee dislocations and patient reported outcomes of patients with primary patellar dislocations managed with surgery (medial patellofemoral ligament reconstruction) compared to non-operative management (a standardized rehabilitation protocol, control group).

NCT ID: NCT05532189 Not yet recruiting - ACL Tear Clinical Trials

Anterior Cruciate Ligament (ACL) Reconstruction With Bone Tendon Bone Autograft With Versus Without Internal Bracing

Start date: December 2023
Phase: N/A
Study type: Interventional

There is no consensus regarding the best surgical management of primary ACL tears. Recent evidence suggests that internal brace augmentation may increase load failure and therefore stabilize the graft in-situ at the time of ACL reconstruction. This prospective randomized controlled trial aims to compare the time to return to activity, and participant reported outcomes in participants with bone-tendon-bone ACL reconstruction with and without (control) internal brace augmentation.

NCT ID: NCT05532150 Not yet recruiting - Clinical trials for Shoulder Dislocation

Conservative Versus Operative - Frist Time Shoulder Dislocations

Start date: December 2023
Phase: N/A
Study type: Interventional

There is no consensus regarding whether rehabilitation or surgical stabilization leads to optimized outcomes for treatment of primary anterior shoulder dislocations. This prospective, randomized controlled trial therefore aims to compare arthroscopic Bankart repair versus physical therapy for the treatment of primary anterior shoulder dislocations.

NCT ID: NCT05531084 Not yet recruiting - Aortic Aneurysm Clinical Trials

Safety and Effectiveness of Surgeon-Modified Stent Grafts forTreatment of Complex Aortic Aneurysms

Assets
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The primary objective of the present study is to evaluate the safety, effectiveness, and clinical outcomes of surgeon-modified fenestrated stent grafts used to treat patients with failed previous infrarenal repairs (failed EVAR) and complex aortic aneurysms (thoracoabdominal, juxtarenal, pararenal, and paravisceral aneurysms).